George Christopher Eliades Oyster Point Pharma, Inc. (OYST) insider trading activity

OYST Quotes by TradingView

George Christopher Eliades is Director of Oyster Point Pharma, Inc.. Currently has a direct ownership of 0 shares of OYST, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2023, when has been sold 28,624 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

George Christopher Eliades Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2023
SELL
Sale (or disposition) back to the issuer
-
28,624 Reduced 100.0%
0 Common Stock
Jun 06 2022
BUY
Grant, award, or other acquisition
-
3,573 Added 11.1%
28,624 Common Stock
Jun 07 2021
BUY
Grant, award, or other acquisition
-
3,466 Added 12.15%
25,051 Common Stock
Apr 02 2021
BUY
Grant, award, or other acquisition
-
21,585 Added 50.0%
21,585 Common Stock
GCE

George Christopher Eliades

Director
Princeton, NJ

Track Institutional and Insider Activities on OYST

Follow Oyster Point Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OYST shares.

Notify only if

Insider Trading

Get notified when an Oyster Point Pharma, Inc. insider buys or sells OYST shares.

Notify only if

News

Receive news related to Oyster Point Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OYST